No. |
Therapeutic area |
Title of study |
Phase of Trial |
No. of patients |
Duration |
Regulatory
|
1. |
Gastroenterology |
Glutathione in Alcoholic Liver disease |
III |
200 |
8 months |
DCGI |
2. |
Cardiovascular |
Telmisartan + Amlodipine + HCTZ tablets in Hypertensive patients |
III |
210 |
10 months |
DCGI |
3. |
Heparin Inj in deep vein thrombosis |
IV |
120 |
4 Months |
Kazhkhistan & Colombia |
4. |
Weight management |
Kionutrime in weight management |
IV |
90 |
6 Months |
Marketing |
5. |
Anti.malarial |
α β – Arteether Injection in Falsiparum Malaria |
III |
220 |
3 months |
DCGI |
6. |
Pain management |
Diclofenac gel in joint pain and muscle sprain |
IV |
100 |
2.5 months |
Marketing |
7. |
Paracetamol 1000 mg SR tablets |
IV |
800 |
9 months |
PMS |
8. |
Synvisc in pain management |
IV |
30 |
2 Years Follow up |
RWLP |
9. |
Anti-aging & Quality of life Nutraceutical product |
Natural Fruit juice with synthetic analogue of Growth hormone (Placebo controlled trial for USA based client) |
III |
75 |
7.5 months |
Currently marketed in UK & Japan
|
10. |
Anemia |
Iron Preparation in female pregnant patients with anaemia |
IV |
60 |
1.5 Months |
Marketing |
11. |
|
r-Erythropoetin Injection in anaemia with chronic renal failure |
III |
120 |
1 year |
DCG |
12. |
Dermatology |
β – Glucan in Psoriasis |
II |
10 |
4 Months |
|
13. |
Aphthofix in mouth ulcer |
II |
20 |
1.5 Months |
|
14. |
Heelfix and Fingurefix in heel cracks & figure cracks |
II |
30 |
3 Months |
Medical Device |
15. |
Permethrine cream in Scabis Double blind placebo controlled trial |
III |
80 |
6 Months |
UK MHRA |
16. |
Dental |
Periocream in root scaling and planning |
II |
30 |
1 month |
Medical device |
17. |
Oncology |
Luprolide in Prostate cancer |
I |
20 + 60 + 30 |
|
PK for US FDA |
18. |
Psychiatry |
Risperidone in Schizophrenic patients |
I |
42 + 36 |
|
PK for EU and US |